Chuck Harbert, PhD
Scientific Advisor, Chief Scientific Officer Emeritus
Chuck Harbert, PhD, worked with Pfizer Central Research for 30 years. Prior to his retirement from Pfizer, Chuck was Vice President of US Exploratory Development and Head of Project Management and Strategic Planning. He has broad and deep experience in drug discovery and early development through phase 2 proof of concept. Chuck led the chemistry team that discovered Zoloft, a highly successful antidepressant drug, as well as CP-55,940, a highly potent cannabinoid that was utilized by NIH scientists to elaborate the endocannabinoid receptor system. He received the Pfizer Achievement Award in 1998, and along with the Zoloft discovery team, was awarded the American Chemical Society Team Innovation Award in 2006. Chuck was endorsed in 2017 by Who’s Who as a Lifetime Achiever in the pharmaceutical industry. He completed an NIH postdoctoral fellowship at Stanford University after earning his PhD in organic chemistry from the University of Missouri.